食管疾病2024，Vol.6Issue(2)：81-94,14.DOI:10.15926/j.cnki.issn2096-7381.2024.02.001
中国食管鳞癌同步放化疗全程管理专家共识
The Expert Consensus on the Whole Processing Management of Concurrent Chemoradiotherapy for Chinese Esophageal Cancer
中国抗癌协会感染性肿瘤专业委员会 1中国抗癌协会食管癌专业委员会 1中国抗癌协会中西医整合食管癌专业委员会 1中国抗癌协会食管肿瘤整合康复专业委员会 1高社干1
作者信息
摘要
Abstract
Esophageal cancer is the fourth most lethal tumor in China,accounting for about half of the world's new cases and deaths each year,of which esophageal squamous cell carcinoma accounts for more than 90％,with a 5-year survival rate of 29.6％.With the advancement of radiotherapy technology and optimization of chemotherapy regimen,concurrent chemoradiotherapy has made breakthrough progress which has pushed the overall treatment situation of esophageal cancer to a fundamental change.Several international guidelines recommend neoadjuvant concurrent chemoradiotherapy plus surgery or definitive concurrent chemoradiotherapy as a side-by-side choice for locally advanced esophageal cancer,which provides a theoretical basis for the"organ preservation"concept for patients with locally resectable esophageal cancer.It provides theoretical basis and new ideas for the concept of"organ preservation"for patients with locally resectable esophageal cancer.In order to better guide the whole processing management of concurrent chemoradiotherapy for esophageal cancer,the Infectious Cancer Committee,Chinese and Western Medicine Integrated Esophageal Cancer Committee and Esophageal Cancer Integrative Rehabilitation Committee of the China Anti-Cancer Association have organized domestic experts in related fields,and after several rounds of in-depth discussions and modifications,systematically sorted out the latest domestic and international guidelines and evidence-based medical evidence,and fully considered the specific conditions of clinical practice in China,to form the present expert consensus.关键词
食管鳞癌/同步放化疗/全程管理/专家共识Key words
esophageal squamous cell carcinoma/concurrent chemoradiotherapy/whole processing management/expert consensus分类
医药卫生引用本文复制引用
中国抗癌协会感染性肿瘤专业委员会,中国抗癌协会食管癌专业委员会,中国抗癌协会中西医整合食管癌专业委员会,中国抗癌协会食管肿瘤整合康复专业委员会,高社干..中国食管鳞癌同步放化疗全程管理专家共识[J].食管疾病,2024,6(2):81-94,14.
